Answers are grounded in this paper and cite their sources.
Demonstrates reliable quantitative lung imaging with ultra-low-dose CT in patients, suggesting major biomarker stability and clinical applicability.
Background/Objectives: Ultra-low-dose computed tomography (ULD-CT) enables substantial radiation reduction compared with routine low-dose computed tomography (LD-CT), but its quantitative reliability across lung imaging biomarkers remains insufficiently characterized. This study aimed to assess the agreement and reliability of quantitative pulmonary imaging biomarkers between paired ULD-CT and LD-CT examinations. Methods: In this prospective study, 48 patients who underwent paired LD-CT and ULD-CT on the same day were analyzed. Whole-lung quantitative biomarkers were categorized into density-derived indices, airway structural metrics, and voxel-based functional biomarkers. Agreement between LD-CT and ULD-CT was evaluated using Bland–Altman analysis and Pearson correlation. Results: Density-based biomarkers demonstrated high concordance, strong correlations, and small systematic biases, indicating robust dose stability. Airway structural metrics showed clinically acceptable agreement with near-perfect reproducibility for cluster-based indices. Voxel-based functional biomarkers exhibited greater dose sensitivity but preserved consistent directional bias. Total lung volume showed excellent reproducibility with minimal bias. Conclusions: ULD-CT enables reliable quantitative lung imaging with clinically acceptable agreement across major biomarker domains, supporting its use as a dose-efficient platform for longitudinal and screening applications.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: